Adding Glaxo’s Alli to diet and exercise can help people lose 50 per cent more weight than with dieting alone. This first U.S. sanctioned diet drug to be sold without a prescription is proving wildly popular.
Alli is the only FDA-approved weight-loss product available to overweight adults, 18 years or older, without a prescription. It combines a clinically-proven product with a comprehensive individualized action plan.
The Back to Nature Foods Company is recalling 26,472 boxes of Back to Nature Sesame Ginger Rice Thins Crackers with a “Best When Used By” date of 16 May 2007, because a small number of boxes were inadvertently manufactured using a milk ingredient seasoning, and no milk ingredients are declared on the label.
GlaxoSmithKline Consumer Healthcare [NYSE: GSK] announces that alli?, the only FDA-approved over-the-counter weight loss product will be on shelves of pharmacies, grocery stores and mass merchandisers nationwide later this week.
CIGNA HealthCare announced that it has signed contracts with three major Washington providers, Swedish Medical Center, MultiCare Health System and Providence Health System.
More than 40 businesses and non-governmental organisations, responding to a European Commission initiative, agreed today to take action to protect European citizens from the harmful use of alcohol.
The US California Assembly approved a bill that would bring health insurers in line with other kinds of insurance in California, requiring companies to defend and get permission for increases in their premiums.
Taking folic acid supplements does not reduce the risk of developing precancerous tumors in the colon and may even increase the risk, a new study has found.
News that scientists have derived cells that behave like stem cells from the skin of a mouse is a major scientific breakthrough that underscores the need to continue human embryonic stem cell research, The Foundation for Taxpayer and Consumer Rights (FTCR) said.
Laundry workers, commercial fishermen and environmental and public health groups petitioned the EPA urging the agency to provide health and safety protections from the endocrine-disrupting chemicals, nonyplphenol and nonylphenol ethoxylates (NPEs).